الصفحة الرئيسية>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Dehydroeffusol

Dehydroeffusol

رقم الكتالوجGC35834

Dehydroeffusol هو الفينانثرين من عشب جنكوس الطبيDehydroeffusol يثبط نمو خلايا سرطان المعدة وتكوين الأورام عن طريق الحث الانتقائي على إجهاد الشبكة الإندوبلازمية الكابتة للورم وموت الخلايا المبرمج المعتدليظهر سمية منخفضة للغاية

Products are for research use only. Not for human use. We do not sell to patients.

Dehydroeffusol التركيب الكيميائي

Cas No.: 137319-34-7

الحجم السعر المخزون الكميّة
5 mg
252٫00
متوفر
10 mg
432٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dehydroeffusol is a phenanthrene from medicinal herb Juncus effuses. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. It shows very low toxicity[1][2].

Dehydroeffusol suppresses the expression of vasculogenic mimicry key gene VE-cadherin[2].Dehydroeffusol decreases the MMP2 expression and activity in gastric cancer cells[2].

[1]. Zhang B, et al. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. Biochem Pharmacol. 2016 Mar 15;104:8-18. [2]. Liu W, et al. Dehydroeffusol effectively inhibits human gastric cancer cell-mediated vasculogenic mimicry with low toxicity. Toxicol Appl Pharmacol. 2015 Sep 1;287(2):98-110.

مراجعات

Review for Dehydroeffusol

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dehydroeffusol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.